# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Gainers Enanta Pharma (NASDAQ: ENTA) stock rose 15.6% to $9.13 during Friday's after-market session. The market value of t...
Viemed Healthcare (NASDAQ:VMD) raises FY2025 sales outlook from $256.000 million-$265.000 million to $271.000 million-$277.000 ...
Viemed Healthcare (NASDAQ:VMD) reported quarterly earnings of $0.08 per share which met the analyst consensus estimate. This is...
Viemed Healthcare (NASDAQ:VMD) raises FY2025 sales outlook from $254.00 million-$265.00 million to $256.00 million-$265.00 mill...
Viemed Healthcare (NASDAQ:VMD) reported quarterly earnings of $0.06 per share which met the analyst consensus estimate. This is...
Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), an in-home clinical care provider of post-acu...